From the patient to the clinical mycology laboratory: How can we optimise microscopy and culture methods for mould identification?

Journal of Clinical Pathology

Volumn 65, Issue 6, 2012, Pages 475-483

  Vyzantiadis, Timoleon Achilleas A ^a   Johnson, Elizabeth M ^b   Kibbler, Christopher C ^c  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; LACTOPHENOL; PHENOL DERIVATIVE; POTASSIUM HYDROXIDE; UNCLASSIFIED DRUG;

ASPERGILLUS; BLOOD SAMPLING; BONE MARROW CULTURE; CEREBROSPINAL FLUID CULTURE; CHEMOTAXONOMY; CLINICAL ASSESSMENT; CLINICAL LABORATORY; EVIDENCE BASED PRACTICE; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUSARIUM; GIEMSA STAIN; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIQUEFACTION; MICROSCOPY; MOLECULAR BIOLOGY; MOULD; MYCOLOGY; MYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SILVER STAINING; STAINING;

ASPERGILLUS; CLASSIFICATION; CULTURE TECHNIQUES; DATABASES, BIBLIOGRAPHIC; FUSARIUM; HUMANS; MICROBIOLOGICAL TECHNIQUES; MYCOLOGY; MYCOSES; PHENOTYPE;

EID: 84861829575     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200500     Document Type: Review

References (75)

1. Rees JR, Pinner RW, Hajjeh RA, et al. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138-47.
2. Perfect JR, Cox GM, Lee JY, et al; Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-33.
3. Balajee SA, Sigler L, Brandt ME. DNA and the classical way: identification of medically important molds in the 21st century. Med Mycol 2007;45:475-90.
4. Zhang N, O'Donnell K, Sutton DA, et al. Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol 2006;44:2186-90.
5. Balajee SA, Gribskov JL, Hanley E, et al. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005;4:625-32.
6. de Hoog GS, Guarro J, Gene J, et al. Atlas of Clinical Fungi. 2nd edn. Centraalbureau voor Schimmelcultures/Universitat Rovira i Virgili, 2000.
7. Evans EGV, Richardson MD. Medical Mycology: A Practical Approach. Oxford, England: IRL Press, 1989.
8. Richardson MD, Warnock DW. Fungal Infection. Diagnosis and Management. 3rd edn. Massachusetts, USA: Blackwell Publishing, Inc., 2003.
9. Doctor Fungus, Lab Procedures: Collection and Transport of Specimens. 2007. http://www.doctorfungus.org/thelabor/sec6.pdf
10. Sutton DA. Specimen collection, transport and processing: mycology. In: Murray PR, ed. Manual of Clinical Microbiology. 9th edn. Washington DC: American Society for microbiology, 2007:1728-36.
11. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996;100:171-8.
12. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986;81:249-54.
13. Meyer RD, Young LS, Armstrong D, et al. Aspergillosis complicating neoplastic disease. Am J Med 1973;54:6-15.
14. Fisher BD, Armstrong D, Yu B, et al. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 1981;71:571-7.
15. Bennett JE. Aspergillus species. In: Mandell G, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases. New York, USA: J Wiley, 1979:2005.
16. http://www.hse.gov.uk/pubns/misc208.pdf
17. Doctor Fungus, Lab Procedures: Processing and Culturing of Specimens. 2007. http://www.doctorfungus.com/thelabor/sec8.pdf
18. Moore GS, Jaciow DM. Mycology for the Clinical Laboratory. Reston, Virginia, USA: Reston Publishing Company, Inc., 1979.
19. Gupta AK, Gupta AK. Postgraduate institute management protocol for invasive Aspergillus flavus sinusitis: is it effective? Int J Infect Dis 2009;13:134-9.
20. Chander J, Chakrabarti A, Sharma A, et al. Evaluation of Calcofluor staining in the diagnosis of fungal corneal ulcer. Mycoses 1993;36:243-5.
21. Bakare N, Rickerts V, Bargon J, et al. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003;46:19-23.
22. Ruchel R, Schaffrinski M. Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener Blankophor. J Clin Microbiol 1999;37:2694-6.
23. Monod M, Baudraz-Rosselet F, Ramelet A, et al. Direct mycological examination in dermatology: a comparison of different methods. Dermatologica 1989;179:183-6.
24. Andreas S, Heindl S, Wattky C, et al. Diagnosis of pulmonary aspergillosis using optical brighteners. Eur Respir J 2000;15:407-11.
25. Phaller MA, McGinnis MR. The laboratory and clinical mycology. In: Anaissie EJ, McGinnis MR, Phaller MA, eds. Clinical Mycology. Philadelphia, PA, USA: Churchill Livingstone, 2003.
26. Woods GL, Schnadig VJ. Histopathology of fungal infections. In: Anaissie EJ, McGinnis MR, Phaller MA, eds. Clinical Mycology. Philadelphia, PA, USA: Churchill Livingstone, 2003.
27. Chandler FW, Watts JC. Pathologic Diagnosis of Fungal Infections. Chicago, USA: ASCP Press, 1987.
28. Musial CE, Cockerill FR 3rd, Roberts GD. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev 1988;1:349-64.
29. Woods GI, Gutierrez Y. Diagnostic Pathology of Infectious Diseases. Philadelphia, USA: Lea & Febiger, 1993.
30. Doctor Fungus, Histopathology. 2007. http://www.doctorfungus.org/ thelabor/histopat.htm
31. Glenn DR, Goodman NL. Laboratory diagnosis. In: Merz WG, Hay RJ, eds. Topley and Wilson's Microbiology & Microbial Infections, Medical Mycology. 10th edn. London, England: ASM Press, 2005:82-96.
32. Patterson TF. Aspergillosis. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York, USA: Oxford University Press, 2003:221-40.
33. Larone DH. Medically Important Fungi: A Guide to Identification. 2nd edn. Washington D.C., USA: ASM Press, 1993.
34. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003;119:854-8.
35. Revankar SG. Dematiaceous fungi. Mycoses 2007;50:91-101.
36. Milne LJR. Direct microscopy. In: Evans EGV, Richardson MD, eds. Medical Mycology. A Practical Approach. Oxford England: IRL Press, 1989:17-45.
37. Brandt ME, Warnock DW. Laboratory aspects of medical mycology. In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York, USA: Oxford University Press, 2003:3-22.
38. Powers CN. Diagnosis of infectious diseases: a cytopathologist's perspective. Clin Microbiol Rev 1998;11:341-65.
39. Sangoi AR, Rogers WM, Longacre TA, et al. Challenges and pitfalls of morphologic identification of fungal infections in histologic and cytologic specimens: a ten-year retrospective review at a single institution. Am J Clin Pathol 2009;131:364-75.
40. De Pauw B, Walsh TJ, Donelly JP, et al. Revise definitions of invasive fungal disease from the European Organization for research and treatment of Cancer/Invasive fungal infections Cooperative group and the National institute of Allergy and infections diseases mycoses study group. Clin Infect Dis 2008;46:1813-21.
41. Ascioglou S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14.
42. Torres HA, Kontoyiannis DP. Hyalohyphomycoses (other than aspergillosis and penicilliosis). In: Dismukes WE, Pappas PG, Sobel JD, eds. Clinical Mycology. New York, USA: Oxford University Press, 2003:252-70.
43. Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis 1999;1:247-61.
44. Anaissie EJ, Bodey GP, Rinaldi MG. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989;8:323-30.
45. Francis P, Walsh TJ. Approaches to management of fungal infections in cancer patients. Oncology (Williston Park) 1992;6:133-44.
46. Paterson PJ, Seaton S, McLaughlin J, et al. Development of molecular methods for the identification of aspergillus and emerging moulds in paraffin wax embedded tissue sections. Mol Pathol 2003;56:368-70.
47. Paterson PJ, Seaton S, McHugh TD, et al. Validation and clinical application of molecular methods for the identification of moulds in tissue. Clin Infect Dis 2006;42:51-6.
48. Beuchat LR. Media for detecting and enumerating yeasts and moulds. Int J Food Microbiol 1992;17:145-58.
49. Beuchat LR. Selective media for detecting and enumerating food borne yeasts. Int J Food Microbiol 1993;19:1-14.
50. Fleet G. Spoilage yeasts. Crit Rev Biotechnol 1992;12:1-44.
51. Koneman EW, Roberts GD, Wright SE. Prcatical Laboratory Mycology. 2nd edn. Baltimore, USA: Williams & Wilkins, 1978.
52. Sutton DA, Fothergill AW, Rinaldi MG. Guide to Clinically Significant Fungi. Baltimore, USA: Williams & Wilkins, 1998.
53. Kontoyiannis DP, Sumoza D, Tarrand J, et al. Significance of aspergillemia in patients with cancer: a 10-year study. Clin Infect Dis 2000;31:188-9.
54. Lionakis MS, Bodey GP, Tarrand JJ, et al. The significance of blood cultures positive for emerging saprophytic moulds in cancer patients. Clin Microbiol Infect 2004;10:922-5.
55. Bille J, Roberts GD, Washington JA 2nd. Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens. Eur J Clin Microbiol 1983;2:22-5.
56. Ellis DH. Clinical Mycology. The Human Opportunistic Mycoses. Underdale, Australia: Phizer Inc., Gillingham Printers Pty Ltd, 1994.
57. Tarrand JJ, Guillot C, Wenglar M, et al. Clinical comparison of the resin-containing BACTEC 26 plus and the isolator 10 blood culturing systems. J Clin Microbiol 1991;29:2245-9.
58. Yeghen T, Kibbler CC, Prentice HG, et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis 2000;31:859-68.
59. Chang YC, Tsai HT, Karos M, et al. THTA, a thermotolerance gene of Aspergillus fumigatus. Fungal Genet Biol 2004;41:888-96.
60. Samson RA. The genus Aspergillus with special regard to the Aspergillus Fumigatus Group. In: Brakhage AA, Bernhard J, Schmidt A, eds. Aspergillus fumigatus. Contrib Microbiol. Vol. 2. Basel: Karger, 1999:5-20.
61. Tarrand JJ, Kontoyiannis D, Han X. Culture incubation conditions affect the growth of Aspergillus Spp. in an in vitro model system of tissue phase fungal growth. 42nd ICAAC Abstracts, San Diego, California, September 27-30, 2002. Washington, DC: ASM Press, 2002. M-909.
62. Morris AJ, Byrne TC, Madden JF, et al. Duration of incubation of fungal cultures. J Clin Microbiol 1996;34:1583-5.
63. Verweij PE, Meis JF. Microbiological diagnosis of invasive fungal infections in transplant recipients. Transpl Infect Dis 2000;2:80-7.
64. Campbell CK, Johnson EM, Philpot CM, et al. Identification of Pathogenic Fungi. London, England: Public health laboratory Service, 1996.
65. Johnson EA. An improved slide culture technique for the study and identification of pathogenic fungi. J Bacteriol 1946;51:689-94.
66. McClenny N. Laboratory detection and identification of Aspergillus species by microscopic observation and culture: the traditional approach. Med Mycol 2005;43 (Suppl 1):S125-8.
67. Raper BK, Fennell DI. The Genus Aspergillus. Baltimore MD, USA: the Williams and Wilkins Company, 1965.
68. Klich MA. Identification of Common Aspergillus Species. Utrecht, the Netherlands: Centraalbureau voor Schimmelcultures, 2002.
69. Mycology Online. Identification of Medically Important Fungi. Australia: The University of Adelaide, 2008. http://www.mycology.adelaide.edu.au/ Fungal-Descriptions
70. Leslie JF, Summerell BA, Bullock S. The Fusarium Laboratory Manual. Ames, Iowa, USA: Wiley-Blackwell, 2006.
71. Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res 2007;111:509-47.
72. Guarro J, Gene J, Stchigel AM. Developments in fungal taxonomy. Clin Microbiol Rev 1999;12:454-500.
73. Klich MA. Identification of clinically relevant aspergilli. Med Mycol 2006;44:S127-31.
74. Balajee SA, Borman AM, Brandt ME, et al. Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol 2009;47:877-84.
75. Balajee SA, Marr KA. Phenotypic and genotypic identification of human pathogenic aspergilli. Future Microbiol 2006;1:435-45.